Development of Pigmentation-Regulating Agents by Drug Repositioning.

Skin color is determined by the processes of melanin synthesis and distribution. Problems in various molecules or signaling pathways involved in melanin synthesis contribute to skin pigmentation defects. Several trials have been conducted on the production of pigmentation-regulating agents, and drug repositioning has emerged as a modern technique to identify new uses for existing drugs. Our research team has researched substances or drugs associated with pigmentation control and, as a result, nilotinib, sorafenib, and ICG-001 have been found to promote pigmentation, while 5-iodotubercidin inhibits pigmentation. Therefore, these substances or medications were suggested as potential therapeutics for pigmentation disorders by drug repositioning.

Citation

Seo-Mi-Gon Jeong, Tae-Jin Yoon. Development of Pigmentation-Regulating Agents by Drug Repositioning. International journal of molecular sciences. 2021 Apr 09;22(8)

Mesh Tags

Substances

PMID: 33918792

search → result